Oxford Pharmascience Group (OXP)

 

OXP Share PerformanceMore

52 week high7.8900 20/05/16
52 week low1.5000 30/12/16
52 week change -2.7500 (-59.46%)
4 week volume24,365,092 22/12/16

Media for (OXP)

Presenter: Marcelo Bravo
12/09/2016
Presenter: Marcelo Bravo
21/04/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Oxford Pharmascience issues company update

Oxford Pharmascience Group has provided a company update, the highlights of which are given below: - Dosing commen...

Company Update

RNS Number: 3020U Oxford Pharmascience Group PLC 17 January 2017 Technical, Clinical and Regulatory Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the following update. Highlights Dosing commenced in the Phase I exploratory phar...

R&D Update

RNS Number: 6768O Oxford Pharmascience Group PLC 09 November 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") R&D Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take provides the following update on the d...

Here's what Neil Woodford is buying and selling

September proved a mixed month for Neil Woodford. Lee Wild reveals what the star fund manager was trading last mon...

Oxford Pharmascience - Interim results 2016

Interim results for the 6 months to 30 June 2016

RNS Number: 1399J Oxford Pharmascience Group PLC 07 September 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Interim results for the six months to 30 June 2016 Oxford Pharmascience Group Plc (AIM: OXP) is pleased to announce its unaudited interim results for the six months to 30 June 2016. HIGHLIGHTS Substantive p...

Oxford Pharmascience downgraded by Beaufort

Beaufort Securities has downgraded its recommendation on Oxford Pharmascience (LON:OXP) to 'hold' (from 'speculative...

Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLC

Beaufort Securities today downgrades its investment rating on Oxford Pharmascience Group PLC (LON:OXP) to hold (fro...

Fundamental DataMore

EPS-0.28
Dividend yield0 %

Latest discussion posts More

  • Wake up time?

    We've had a good slumber, all the way since last June. m
    9-Jan-2017
    mantrova
  • Rising with volume >>> bullish

    A nice rise for the last few days as the volume has been rising from the first day. The chart just look bullish as the 2 weeks flat bottom is now rising on the right side, ...
    27-Oct-2016
    BuySel
  • hoping for some good news tomorrow

    a JV perhaps
    3-Mar-2016
    one4all

Users' HoldingsMore

Users who hold Oxford Pharmascience Group also hold..
ID:ISIN:VGG9828A119415%
SIRIUS MINERALS15%
GLAXOSMITHKLINE13%
XTRACT11%
OXFORD BIOMED.11%

Codes & Symbols

ISINGB00B3LXPB43
SymbolsOXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP